None listed
Conditions
Interventions
Intervention1: 2% Lignocaine with 1:200000 adrenaline and dexmedetomidine: The selected patients will be administered dexmedetomidine in combination with lignocaine 2% as an adjuvant with 1:200,000 ad
Sponsors
Dr Heena Khan
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA class I patient 2.Age group18-40 years 3.Bilateral similar impaction (with same classification and difficulty index)
Exclusion criteria
Exclusion criteria: 1.Patients with a known history of an allergy or hypersensitivity to lignocaine or dexmedetomidine, 2.Pregnant or lactating mothers 3.Patients with acute pericoronitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Faster onset of local anaesthesia, prolonged duration of local anaesthesia, decrease in bleeding intraoperativelyTimepoint: One and half year | — |
Secondary
| Measure | Time frame |
|---|---|
| Better hemodynamic stabilityTimepoint: Two weeks;Decrease in bleedingTimepoint: Assessed after surgical extraction immediately;Faster action of onsetTimepoint: Once LA is injected (2-3 minutes);Patient experienceTimepoint: Post operatively 1 - 2 hours;Prolong duration of anaesthesiaTimepoint: Assessed from injecting LA to when the effect is weaned of (usually 2-3 hours) | — |
Countries
India
Contacts
Public ContactDr Heena Khan
Yenepoya Dental College
Outcome results
None listed